Pharmaceutical News

RSS

RUB biologists report that vitamin P ensures survival of motor neurons in culture

Biologists from the Ruhr-Universit-t Bochum have explored how to protect neurons that control movements from dying off.

3 Apr 2013

Biogen acquires TYSABRI stake from Elan

Biogen Idec today announced it has completed its purchase of Elan Corporation's interest in TYSABRI (natalizumab) and has gained full strategic, commercial and decision-making rights to TYSABRI.

3 Apr 2013

UC Davis scientists find mechanism in metabolized omega-3 fatty acid that helps combat cancer

A team of UC Davis scientists has found that a product resulting from a metabolized omega-3 fatty acid helps combat cancer by cutting off the supply of oxygen and nutrients that fuel tumor growth and spread of the disease.

3 Apr 2013

Minocycline can help reduce hemorrhagic stroke damage

A new study will help determine if an antibiotic is a partial antidote for the poisonous effect blood has on the brain following a hemorrhagic stroke, researchers say.

2 Apr 2013

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

2 Apr 2013

ShopSmart magazine's April issue features answers to common questions about Vitamin D

Vitamin D has been touted as the answer to all kinds of health problems, but many of these claims are overblown. The April 2013 issue of ShopSmart magazine, from Consumer Reports, features answers to some of the most common questions about Vitamin D and names the best from its tests of 32 products.

2 Apr 2013

Report highlights ecological cost of pharmaceutical waste

Pharmaceuticals commonly found in the environment are disrupting streams, with unknown impacts on aquatic life and water quality.

2 Apr 2013

Modifiable lifestyle factors may prevent progression of Barrett's-related esophageal cancer

An estimated 20 million Americans have chronic heartburn. About 2 million of these people have Barrett's esophagus, a precancerous condition that affects the tube that carries food from the mouth to the stomach.

2 Apr 2013

India's Supreme Court rules against Novartis AG in 'landmark' patent case

"India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines," the Associated Press reports.

2 Apr 2013

pSivida announces resubmission of ILUVIEN NDA to FDA for chronic diabetic macular edema

pSivida Corp., a specialty pharmaceutical company that is a leader in the development of sustained release ophthalmic drug treatments, today announced that its licensee Alimera Sciences, Inc. reported the submission of its response to the second Complete Response Letter from the U.S. Food and Drug Administration with respect to ILUVIEN for chronic diabetic macular edema.

2 Apr 2013

Sildenafil may also serve as weight loss aid, shows new research

Although sildenafil is best known for promoting erections, it may also serve as a weight loss aid by coaxing our bodies to store more healthy "brown fat" relative to unhealthy "white fat" than it would otherwise do on its own.

2 Apr 2013

BioCryst Pharmaceuticals receives preliminary comment letter from FDA on peramivir

BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.

1 Apr 2013

New study shows varicella vaccine neutralizes chicken pox

Chicken pox, the childhood affliction of earlier generations, has been largely neutralized by the varicella vaccine, according to a new study by the Kaiser Permanente Vaccine Study Center, which appears in the current online issue of Pediatrics.

1 Apr 2013

IGDRASOL to present updates on Cynviloq at AACR annual meeting

Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its development of Cynviloq (IG-001) at the annual meeting of the American Association for Cancer Research in Washington, DC (April 6th to 10th).

1 Apr 2013

Biological psychiatry shares progress in identifying genomic predictors of antidepressant response

Antidepressants are commonly prescribed for the treatment of depression, but many individuals do not experience symptom relief from treatment.

30 Mar 2013

New technique for vaccine design could prove useful against HIV, other viral strains

A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly useful against HIV and other fast-changing viruses.

30 Mar 2013

Recent findings reveal correlations between autism prevalence, childhood vaccination

Recent finds in two articles in the Journal of Toxicology and Environmental Health, Part A indicate correlations between autism and vaccinations.

30 Mar 2013

Study highlights cost savings of generic drugs

Consumer Reports offers new analysis that finds not all patients realize they can save big by shopping around for drugs. Meanwhile, two outlets look at insurance coverage issues for couples.

30 Mar 2013

Researchers find no association between receiving too many vaccines too soon and autism

Although scientific evidence suggests that vaccines do not cause autism, approximately one-third of parents continue to express concern that they do; nearly 1 in 10 parents refuse or delay vaccinations because they believe it is safer than following the Centers for Disease Control and Prevention's schedule.

30 Mar 2013

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

The U.S. Food and Drug Administration today approved Invokana (canaglifozin) tablets, used with diet and exercise, to improve glycemic control in adults with type 2 diabetes.

30 Mar 2013

Pharmaceutical News

RUB biologists report that vitamin P ensures survival of motor neurons in culture

Biogen acquires TYSABRI stake from Elan

UC Davis scientists find mechanism in metabolized omega-3 fatty acid that helps combat cancer

Minocycline can help reduce hemorrhagic stroke damage

Study: Pradaxa drug may increase risk and severity of viral infections

ShopSmart magazine's April issue features answers to common questions about Vitamin D

Report highlights ecological cost of pharmaceutical waste

Modifiable lifestyle factors may prevent progression of Barrett's-related esophageal cancer

India's Supreme Court rules against Novartis AG in 'landmark' patent case

pSivida announces resubmission of ILUVIEN NDA to FDA for chronic diabetic macular edema

Sildenafil may also serve as weight loss aid, shows new research

BioCryst Pharmaceuticals receives preliminary comment letter from FDA on peramivir

New study shows varicella vaccine neutralizes chicken pox

IGDRASOL to present updates on Cynviloq at AACR annual meeting

Biological psychiatry shares progress in identifying genomic predictors of antidepressant response

New technique for vaccine design could prove useful against HIV, other viral strains

Recent findings reveal correlations between autism prevalence, childhood vaccination

Study highlights cost savings of generic drugs

Researchers find no association between receiving too many vaccines too soon and autism

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News